Ullman Medical

Ullman Medical is an Israeli biotechnology company dedicated to developing plant-based drugs for the treatment of psoriasis and other immunodeficiency diseases. The company is developing a plant extract as a topical treatment for psoriasis. In early studies, the compound has shown positive human clinical data. The compound has also demonstrated preclinical evidence of being non-toxic and anti-angiogenic, which can be used to treat eye diseases, arthritis, and certain cancers. The company aims to develop the compound into a topical treatment for psoriasis and a therapeutic agent for immunodeficiency diseases.